DCF — WILSON MEDICAL CENTER
Enterprise Value: $-99.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-99.0M
Enterprise Value
$-34.0M
PV of Cash Flows
$-65.0M
PV of Terminal Value
$-104.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $142.6M | $-4.7M | -3.0% | $-10.7M | $-9.8M |
| Year 2 | $146.9M | $-3.4M | -2.0% | $-9.6M | $-7.9M |
| Year 3 | $151.3M | $-2.0M | -1.0% | $-8.4M | $-6.3M |
| Year 4 | $155.8M | $-1.2M | -1.0% | $-7.8M | $-5.3M |
| Year 5 | $160.5M | $-0.9M | -1.0% | $-7.7M | $-4.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-99.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$138.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.03789774083562936
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5